Recent Posts

• Meet Inven2 at the Nordic Life Science Days
• Licensing validates Norwegian platform technology for the development of tailored monoclonal antibodies
• Authera lands collaborative agreement with argenx
• Technology from the University of Oslo is on its way to the moon.
• Summary of 2022